Select language:

If you would like to see your event on this calendar, please email

Events must be related to the field of gynecologic cancers with the target audience of clinicians, researchers, or advocates (patient/survivors/family members/caregivers).

Loading Events

« All Events

  • This event has passed.

Second-Line Treatment Options for Patients with Recurrent Cervical Cancer. Review of Current Treatment and Future Directions

Dec 7, 2022 @ 10:30 am - 11:30 am

Join us for an overview of the InnovaTV 204 trial data along with InnovaTV 205 data, as well as ongoing trials including InnovaTV 301.

Wednesday, December 7, 2022
10:30 AM ET | See all time zones
Duration approximately 30 minutes
Supported in part by Seagen

Register Here

Robert Coleman, MD
Chief Scientific Officer,
US Oncology Research


Dec 7, 2022
10:30 am - 11:30 am
Event Categories: